Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis [TimeSeries]

ABSTRACT: An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis [TimeSeries]

PROVIDER: PRJNA882100 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21629100_1.fastq.gz	Fastqsanger.gz
	SRR21629100_2.fastq.gz	Fastqsanger.gz
	SRR21629101_1.fastq.gz	Fastqsanger.gz
	SRR21629101_2.fastq.gz	Fastqsanger.gz
	SRR21629102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 50

Similar Datasets

An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis

Project description:An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis

| PRJNA900598 | ENA

An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis [TimeSeries]

Project description:Pulmonary fibrosis (PF) is a progressive disease with a poor prognosis and lack of effective treatments. Therefore, identifying effective therapeutic modalities is required to improve outcome. However, the lack of predictive progressive disease biomarkers in the clinic causes a significant gap in the preclinical to clinical translational process. Here, we assessed and identified progressive alterations in pulmonary function, transcriptomics, and metabolomics in mice lungs at 7, 14, 21, and 28 days after a single dose of oropharyngeal bleomycin. By integrating multi-omics data, we identified two central gene subnetworks associated with multiple critical pathological changes in transcriptomics and metabolomics as well as pulmonary function. We presented a multi-omics-based framework to establish a translational link between the bleomycin-induced PF model in mice and human idiopathic pulmonary fibrosis to identify druggable targets and test therapeutic candidates. Our study also indicated peripheral CB1R antagonism as a rational therapeutic target for clinical translation in PF.

2023-04-11 | GSE213709 | GEO

An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis [CB1R KO]

Project description:An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis [CB1R KO]

| PRJNA900595 | ENA

An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis [CB1R KO]

2023-04-11 | GSE217814 | GEO

An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis.

Project description:Pulmonary fibrosis (PF) is a heterogeneous disease with a poor prognosis. Therefore, identifying additional therapeutic modalities is required to improve outcome. However, the lack of biomarkers of disease progression hampers the preclinical to clinical translational process. Here, this work assesses and identifies progressive alterations in pulmonary function, transcriptomics, and metabolomics in the mouse lung at 7, 14, 21, and 28 days after a single dose of oropharyngeal bleomycin. By integrating multi-omics data, this work identifies two central gene subnetworks associated with multiple critical pathological changes in transcriptomics and metabolomics as well as pulmonary function. This work presents a multi-omics-based framework to establish a translational link between the bleomycin-induced PF model in mice and human idiopathic pulmonary fibrosis to identify druggable targets and test therapeutic candidates. This work also indicates peripheral cannabinoid receptor 1 (CB1 R) antagonism as a rational therapeutic target for clinical translation in PF. Mouse Lung Fibrosis Atlas can be accessed freely at https://niaaa.nih.gov/mouselungfibrosisatlas.

| S-EPMC10238219 | biostudies-literature

Integrative Multiomics analysis to infer Covid-19 biological insights

Project description:Integrative Multiomics (Proteomics, Metabolomics) analysis to infer Covid-19 biological insights

2022-05-30 | MSV000089568 | MassIVE

An integrative multiomics framework for identification of therapeutic targets in pulmonary fibrosis

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-04-11 | GSE217816 | GEO

GNPS Integrative Multiomics analysis to infer Covid-19 biological insights

Project description:Integrative Multiomics (Proteomics, Metabolomics) analysis to infer Covid-19 biological insights

2022-05-30 | MSV000089568 | GNPS

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Project description:Integrative multiomics can elucidate pulmonary arterial hypertension (PAH) pathobiology but procuring human PAH lung samples is rare. Here, we leverage transcriptomic profiling and deep phenotyping of the largest multicenter PAH lung biobank to date (96 disease and 52 control) by integration with clinicopathologic data, genome-wide association studies, Bayesian regulatory networks, single-cell transcriptomics, and pharmacotranscriptomics. We identify two potentially protective gene network modules associated with vascular cells, and we validated ASPN, coding for asporin, as a key hub gene that is upregulated as a compensatory response to counteract PAH. Specifically, we find that asporin is upregulated in lungs and plasma of multiple independent PAH cohorts and correlates with reduced PAH severity. We show asporin inhibits proliferation and TGF-β/pSMAD2/3 signaling in pulmonary artery smooth muscle cells from PAH lungs. Finally, we demonstrate in Sugen-hypoxia rats that ASPN knockdown exacerbated PAH while recombinant asporin attenuated PAH. Our integrative systems biology approach to dissect the PAH lung transcriptome uncovered asporin as a novel protective target with therapeutic potential in PAH.

2024-05-22 | GSE254617 | GEO

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Project description:Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

| PRJNA1071142 | ENA